Skip to main content
Catherine  Smith

Professor Catherine Smith

Professor of Dermatology & Therapeutics

Biography

Catherine is adjunct Professor of Dermatology and Therapeutics at St John’s Institute of Dermatology, Kings College London, an NIHR Senior Investigator, and Consultant Dermatologist leading national specialised services for adults with severe psoriasis and eczema at Guys and St Thomas NHS Foundation Trust.

Her research aims to deliver disease remission for people with inflammatory skin disease using data-driven, proactive, inclusive precision medicine strategies, and involves national and international collaboration. She’s also interested in guideline development and implementation in the UK and Europe so that research findings influence practice.

    Research

    STRU banner thumbnail (1)
    Skin Therapy Research Unit

    The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.

    Transdiagnostic biological clustering
    Clinical Diagnostics Development Unit (CDDU)

    The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.

    News

    Meet the Spinouts on King's Spinout Accelerator

    10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.

    King's Spinout Accelerator cohort standing on steps

    Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

    People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

    inflammatory arthritis 780x450

    Professor Catherine Smith appointed NIHR Senior Investigator

    The role is reserved for outstanding leaders of patient and people-based research.

    Catherine Smith

    Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover

    The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...

    Severe Psoriasis

    COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate

    The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...

    covid vaccine

      Research

      STRU banner thumbnail (1)
      Skin Therapy Research Unit

      The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.

      Transdiagnostic biological clustering
      Clinical Diagnostics Development Unit (CDDU)

      The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.

      News

      Meet the Spinouts on King's Spinout Accelerator

      10 spinouts derived from King’s research community will explore the commercial potential of their research on the King’s Spinout Accelerator.

      King's Spinout Accelerator cohort standing on steps

      Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

      People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

      inflammatory arthritis 780x450

      Professor Catherine Smith appointed NIHR Senior Investigator

      The role is reserved for outstanding leaders of patient and people-based research.

      Catherine Smith

      Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover

      The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...

      Severe Psoriasis

      COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate

      The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...

      covid vaccine